Researchers quantitatively investigated the mechanisms by which topical treatments modulate skin sensory perceptions, linking biomechanical changes in the skin to activation of cutaneous mechanoreceptors and subsequent neural signaling and correlating these changes to subjective sensory experiences reported by individuals.
Corner Therapeutics to hyperactivate ‘the brains of the immune system’ with $54M launch
Corner Therapeutics’ $54 million Series A will be used to bring new immunotherapies for cancer and infectious diseases into the clinic, the company said Thursday.
April 19, 2024